Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma
Phase of Trial: Phase II
Latest Information Update: 25 Jul 2017
At a glance
- Drugs Vinorelbine (Primary)
- Indications Glioma
- Focus Therapeutic Use
- 19 Jul 2017 Planned End Date changed from 1 Nov 2017 to 1 Dec 2019.
- 19 Jul 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Aug 2017.
- 19 Jul 2017 Status changed from recruiting to suspended.